TMAO is a metabolite produced when gut bacteria process choline and carnitine from dietary animal products, then further metabolized by the liver.
Elevated TMAO is associated with increased cardiovascular risk, kidney dysfunction, and gut microbiome imbalance. It's influenced by diet composition and gut bacterial populations, making it a window into diet-microbiome-cardiovascular interactions.
Optimal TMAO: 0-3 µmol/L.
Typically re-tested every 12 weeks.
It is an emerging marker rather than a routine one. A single value is a snapshot of diet, gut bacteria and kidney clearance on the day of the draw, not a verdict on your heart.
TMAO is a gut-microbiome-derived metabolite measured in blood or urine, formed when the liver oxidises trimethylamine (TMA) that intestinal bacteria generate from dietary precursors 1.
The pathway runs in three steps. First, you eat compounds that contain a trimethylamine group: choline (concentrated in egg yolk, liver and some meats), L-carnitine (concentrated in red meat), betaine and phosphatidylcholine. Second, specific gut bacteria carrying the right enzymes cleave those compounds and release TMA, a volatile gas that is absorbed through the intestinal wall. Third, TMA travels to the liver, where enzymes in the flavin-containing monooxygenase family, chiefly FMO3, convert it into TMAO 2. The kidneys then clear most of it into urine.
That three-part route explains why TMAO behaves unlike a classic liver or lipid marker. Your level depends on what you ate, which bacteria are living in your gut, how actively your liver oxidises TMA, and how well your kidneys are clearing the product. Two people can eat the same meal and land in different places.
There is also a direct dietary route. Many marine fish and shellfish contain preformed TMAO as an osmolyte that helps them tolerate pressure and salinity, so eating seafood can raise circulating TMAO within hours without any bacterial step at all 3. This is one reason a single reading taken after a seafood meal can be misleading.
TMAO matters because a higher circulating level is associated with atherosclerotic cardiovascular disease, and because the mechanism is biologically plausible rather than purely statistical.
Reviews of the cardiovascular literature describe TMAO as a candidate marker of atherosclerotic vascular disease, with higher levels reported alongside greater disease burden in observational cohorts 4. Mechanistic work suggests several routes by which TMAO may act on the vessel wall. Research indicates it is associated with altered cholesterol handling in macrophages, promotion of foam-cell formation, endothelial activation and heightened platelet reactivity 5. Those are the same processes that drive plaque formation and thrombosis.
The stroke literature follows a similar line. Reviews of the gut-microbe axis in ischemic stroke report associations between elevated TMAO and stroke risk and outcome, while noting that the human evidence is largely observational 6. A separate review of cerebral stroke risk reaches a comparable conclusion, describing TMAO as a biologically plausible contributor whose causal role in people is still being worked out 7.
Two honest caveats belong here. First, association is not causation, and some of the strongest associations come from populations with reduced kidney function, where clearance alone raises the number. Second, TMAO is not part of standard cardiovascular risk scoring, and no major guideline positions it as a screening test for the general population. It is best read as one marker sitting beside lipids, inflammation and blood pressure, not as a replacement for them.
What it does add is a window on the diet-microbiome interface. Conventional lipid markers tell you about particles in circulation. TMAO tells you something about the upstream interaction between what you eat and who is living in your gut 8.
Most laboratories report fasting plasma TMAO against a typical reference range of 0 to 6.2 µmol/L, while FitScript's optimal range sits lower, at 0 to 3 µmol/L.
| Measure | Typical lab reference range | FitScript optimal range |
|---|---|---|
| TMAO, plasma or serum | 0 to 6.2 µmol/L | 0 to 3 µmol/L |
Reference ranges vary by laboratory, assay method, age and sex, so always read your result against the range printed on your own report. No sex-specific or age-specific optimal ranges are published for this marker here, so treat the single range above as applying to adults generally.
FitScript's optimal range is an optimization target, not a diagnostic cut-off. A value above 3 µmol/L but inside the standard reference range is not a diagnosis of anything. It is a prompt to look at diet pattern, kidney clearance and the rest of your cardiovascular panel together. TMAO is also measured by mass spectrometry, and values are not reliably comparable between laboratories, so track trends within one lab rather than comparing numbers across providers.
A high TMAO result means more of the metabolite was circulating at the time of the draw, which commonly reflects recent diet, gut-microbiome composition, reduced kidney clearance, or a combination of all three.
Symptoms people report. TMAO itself produces no recognised symptom pattern. It is not something you feel. People who turn out to have elevated levels usually arrive at the test for another reason, such as a strong family history of heart disease, an abnormal lipid panel, or an interest in cardiovascular risk beyond cholesterol. Where symptoms are present, they typically belong to the underlying situation rather than to TMAO: fatigue and swelling in reduced kidney function, or exertional chest discomfort in established coronary disease. A separate and unrelated condition, trimethylaminuria, involves impaired conversion of TMA to TMAO and produces a distinctive body odour, which is effectively the mirror image of the usual picture.
Common causes. The frequent contributors are a diet high in red meat, egg yolk, organ meats or carnitine-containing supplements; a recent seafood or shellfish meal, since many marine species carry preformed TMAO 3; a gut-microbiome profile rich in TMA-producing bacteria; and reduced renal clearance. Kidney function deserves particular emphasis. In people receiving hemodialysis, circulating TMAO is markedly elevated and research has linked higher levels in that group to cardiovascular events 9. Individual variation in liver FMO3 activity adds a further layer 2.
Long-term health impact. Persistently elevated TMAO is associated in observational research with atherosclerotic burden, major cardiovascular events and stroke risk 4 7. That is an association, not a sentence. The reasonable reading of a high result is that it is suboptimal and worth investigating alongside kidney markers and a full lipid and inflammation picture. A markedly elevated value, especially with any sign of reduced kidney function, is worth discussing with a clinician promptly rather than filing away.
A low TMAO result usually means little TMA was being produced or absorbed around the time of the test, most often because of a plant-forward diet, low intake of choline and carnitine-rich foods, or a gut-microbiome profile with few TMA-producing organisms.
Symptoms people report. None attributable to the marker. Low TMAO is generally regarded as unremarkable and is not linked to a recognised deficiency syndrome. If someone with a very low value feels unwell, the explanation almost always lies elsewhere, and markers of protein, iron, B12 and thyroid status are usually more informative.
Common causes. Vegetarian and vegan eating patterns are a well-described cause. Research comparing vegetarians with omnivores has found lower circulating TMAO in vegetarians, alongside notable within-person variation over time 10. Simply fasting properly before the draw, with no seafood or red meat in the preceding day or two, will also pull the number lower.
Long-term health impact. There is no established downside to a low TMAO value, and low levels are what most dietary and microbiome-directed strategies aim toward. One caution is worth stating plainly: a low TMAO reading says nothing about the rest of your cardiovascular risk. Lipoprotein particle number, blood pressure, glucose regulation and inflammation all operate independently of this pathway, and a reassuring TMAO does not offset an unfavourable reading elsewhere.
TMAO is one of the more volatile markers on a panel, and several ordinary factors can move a single reading substantially.
Testing conditions. The most important variable is what you ate before the draw. Preformed TMAO in marine fish and shellfish can raise circulating levels within hours 3, so a sample taken the morning after a seafood dinner is not comparable to a fasting sample after a typical day. Most protocols use an overnight fast. Day-to-day biological variation is real too, and research in vegetarians and omnivores has documented meaningful fluctuation in repeat measurements from the same person 10. For that reason a trend across several draws under consistent conditions tells you far more than any single number.
Diet. A randomised crossover trial comparing plant-based meat alternatives with animal meat in generally healthy adults found lower TMAO during the plant-based phase in participants who had started on the animal-meat arm, though the response was not uniform across the group 11. Broader reviews of diet and this pathway reach a similar conclusion, that intake of choline-rich and carnitine-rich animal foods is associated with higher levels while plant-forward patterns are associated with lower ones 8.
Medications and supplements. Carnitine and choline supplements supply precursor directly. Anything that alters kidney clearance will shift the number for reasons that have nothing to do with diet 9. Never start or stop a medication to influence a lab value. A licensed provider evaluates whether any change is appropriate for you.
Emerging approaches. Research is actively exploring compounds that inhibit the bacterial TMA-forming enzymes or modulate the microbiome as a way to lower TMAO 12. These are experimental and clinician-gated, not established options, and no dosing or administration guidance belongs in a page like this one.
FitScript does not currently test TMAO in a panel. The membership covers 150+ biomarkers tested per year, and this particular metabolite is not among them, largely because it remains an emerging marker rather than a standard clinical one.
If you already have a TMAO result from another laboratory, you can upload your existing labs and Atlas, FitScript's AI health advisor, will read it alongside the markers you do have on file. That context is the point. A TMAO value interpreted on its own invites over-reading. The same value read beside your lipid particle data, inflammatory markers and kidney filtration tells a far more coherent story, and Atlas builds that reading into your FitScript, the personalized output written from your own biology.
Where a result and the surrounding picture suggest that a prescription option is worth considering, a licensed provider reviews the member and decides whether it is appropriate. Nothing on this page replaces that evaluation.
Because TMAO sits on a cardiovascular and renal axis, the markers that give it meaning are the ones measuring lipoprotein burden, inflammation and kidney clearance.
Apolipoprotein B counts the atherogenic particles actually capable of entering the arterial wall, which makes it the most direct companion to any marker thought to influence plaque biology. LDL Cholesterol measures the cholesterol carried within those particles and remains the primary lipid target in routine care. Cholesterol - Total gives the overall pool, and the Cholesterol / HDL Ratio frames that pool against protective particles, which often reveals more than either figure alone. C-Reactive Protein captures the inflammatory component of vascular disease, relevant because research suggests TMAO may act partly through endothelial activation and inflammatory signalling 5. eGFR estimates kidney filtration and is arguably the single most important marker to read next to TMAO, since reduced clearance raises levels independently of anything happening in the gut 9.
TMAO is a metabolite produced through a collaboration between your gut bacteria, your diet and your liver, then cleared by your kidneys. Research associates higher circulating levels with atherosclerotic cardiovascular disease and stroke risk, while acknowledging that most of the human data is observational and that kidney function confounds a great deal of it 1 6. Typical laboratory ranges run to 6.2 µmol/L, FitScript's optimal range is lower, and a single reading is a snapshot shaped by your last few meals.
This page is educational and is not medical advice. Discuss your results and any proposed treatment with a clinician or licensed provider who can see your full history.
TMAO stands for trimethylamine N-oxide. It is a small molecule formed when your liver oxidises trimethylamine, a gas that gut bacteria release from dietary choline, L-carnitine, betaine and phosphatidylcholine. Some marine fish and shellfish also contain preformed TMAO, which is absorbed directly without any bacterial step.
Laboratories commonly report plasma TMAO against a typical reference range of 0 to 6.2 µmol/L. FitScript's optimal range is lower, at 0 to 3 µmol/L, which is an optimization target rather than a diagnostic cut-off. Reference ranges vary by lab, assay, age and sex, so read your result against the range printed on your own report.
High TMAO produces no recognised symptom pattern of its own. You cannot feel it. Where symptoms are present, they usually belong to an underlying situation such as reduced kidney function or established vascular disease rather than to the metabolite itself. This is why the marker is identified through bloodwork and not through how someone feels.
Yes, often sharply and briefly. Many marine fish and shellfish carry preformed TMAO as an osmolyte, and circulating levels can rise within hours of eating them. That is one reason a fasting sample matters and why a single elevated reading taken after a seafood meal should not be over-interpreted.
No. Higher TMAO is associated with atherosclerotic cardiovascular disease and stroke risk, but association is not diagnosis, and no single value identifies a condition. A high result is suboptimal and worth reviewing alongside lipid, inflammatory and kidney markers with a clinician who can see your full history.
Substantially. The kidneys clear most circulating TMAO into urine, so reduced filtration raises levels independently of diet or gut bacteria. Reading eGFR alongside TMAO is one of the most useful ways to interpret an elevated result correctly.
Research suggests it can. Plant-forward eating patterns are associated with lower levels. Responses vary between individuals because gut-microbiome composition differs.
Not at present. FitScript's membership covers 150+ biomarkers tested per year, and TMAO is not currently among them. If you already have a result from another laboratory, you can upload your existing labs and Atlas will read it alongside your other markers when building your FitScript.